Can-Fite BioPharma (CANF) Reports $5 Million Registered Direct Offering
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (NYSE: CANF) a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE